Our analyses identified that TRGV9 transcripts were highly expressed compared to other TRGV genes, suggesting that Vγ9Vδ2 T cells may be enriched in prostate cancer, and particularly in bone metastases (Fig. 1, A and B). Here, TRGV9 is linked to prostate cancer.